 |
|
|
| |
CD4 T-cell, CD4/CD8 Ratio Improvement and a General Reduction in Inflammatory Biomarkers With Low-Level Viremia (LLV) up to Week 192 With Fostemsavir (FTR)-Based Regimens in Individuals With Multidrug-Resistant (MDR) HIV-1
|
| |
| |
IDWeek 2024; October 16-19, 2024; Los Angeles, CA
Vincenzo Spagnuolo,1 Natalia Gregori,2 Iacopo Marcon,2 Fangfang Du,3 Bo Li,3 Marcia Wang,3 Alftan Dyson,4br clear="all" />
Manyu Prakash,5 Andrew Clark5br clear="all" />
1IRCCS San Raffaele Scientific Institute, Milan, Italy; 2ViiV Healthcare, Verona, Italy; 3GSK, br clear="all" />
Collegeville, PA, USA; 4ViiV Healthcare, Durham, NC, USA; 5ViiV Healthcare, Brentford, UK
|
| |
|
|
|
|
|
